
zzso zzso are zzso zzso Several experimental studies suggest that primary zzso growth, zzso and zzso require zzso zzso zzso is a complex zzso process under the control of positive and negative soluble zzso A mutual stimulation occurs between zzso and zzso cells by zzso zzso zzso is necessary, but not zzso as the single event for zzso zzso There is, however, compelling evidence that acquisition of the zzso zzso is a common zzso for zzso zzso and that active zzso is associated with other molecular mechanisms leading to zzso zzso Experimental research suggests that it is possible to block zzso by specific zzso agents, and that zzso of zzso activity is associated with zzso zzso in animals with different types of zzso The more promising zzso agents for clinical testing are: naturally occurring zzso of zzso zzso zzso zzso zzso and zzso specific zzso of zzso cell growth zzso zzso zzso and zzso agents zzso zzso peptides zzso to zzso growth factor or vascular zzso growth factor, zzso and zzso zzso and others) or their zzso agents that interfere with vascular basement membrane and zzso zzso zzso zzso zzso zzso steroids and zzso zzso molecules zzso such as zzso alpha v beta 3, and zzso drugs that zzso zzso by diverse mechanisms of zzso zzso therapy is to be distinguished from vascular zzso Gene therapy aimed to block zzso is also a feasible zzso strategy in animals bearing experimental zzso zzso therapy represents one of the more promising new approaches to zzso therapy and it is already in early clinical zzso Because zzso therapy is aimed at blocking zzso growth zzso through zzso of zzso zzso agents need to be developed and evaluated as biological response zzso zzso adequate and well designed clinical trials should be performed for a proper evaluation of zzso agents, by determination and monitoring of surrogate markers of zzso zzso 

